Cover Image
市場調查報告書

灰指甲:主要10個國家的市場預測

Onychomycosis Forecast in 10 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 339846
出版日期 內容資訊 英文 44 Pages
訂單完成後即時交付
價格
Back to Top
灰指甲:主要10個國家的市場預測 Onychomycosis Forecast in 10 Major Markets 2015-2025
出版日期: 2015年08月01日 內容資訊: 英文 44 Pages
簡介

灰指甲是發生在指尖、腳指甲的真菌感染疾病。最常見的病原體有紅癬菌和毛瘡癬菌等菌類病原體。

本報告提供全球主要10個國家(美國,法國,德國,義大利,西班牙,英國,波蘭巴西,日本,印度) 的灰指甲發病情形相關分析,提供您疾病概要和目前的患病人數,性別·各年代 (以五歲為區分) 的詳細情況,各地區·各民族趨勢,風險要素,疾病診斷與預後,主要的症狀和併發症,未來性的趨勢預測 (今後10年份) 等資訊,為您概述為以下內容。

目錄

  • 圖表
  • 概要
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷
  • 各地區/各民族的差異
  • 疾病的預後與臨床經過
  • 疾病相關的主要併發症/特徵
  • 患者數的定量化技術
  • 灰指甲的最大患病人數
  • 主要的病原體
  • 疾病的平均持續期間
  • 疾病重大的併發症
  • 感染疾病的主要前兆
  • 參考文獻
  • 附錄
目錄
Product Code: ONYC0010815

Onychomycosis is a fungal infection of the nail which occurs in the hands or feet. The more notable causative agents include the fungal pathogens Trichophyton rubrum and Trichophyton mentagrophytes. This report provides the current prevalent population for Onychomycosis across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Poland, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Onychomycosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Onychomycosis include:

  • Tinea pedis infections
  • Diabetes
  • Peripheral vascular disease
  • HIV / AIDS
  • Hypercholesterolaemia
  • Osteoarticular disease
  • Psoriasis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Onychomycosis's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Onychomycosis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Useful in the identification and trend of the prevalence numbers for the different causative agents of Onychomycosis.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Onychomycosis's prevalent population.
  • Identify sub-populations within Onychomycosis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Onychomycosis patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR

Table of Contents

  • List of Tables & Figures
  • Overview
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Co-morbid Conditions/Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Onychomycosis
  • Main Causative Agent
  • Average Duration of Disease
  • Significant Co-morbidities of Disease
  • Main Signs of Infection
  • References
  • Appendix

List of Tables & Figures

  • Prevalence of clinically diagnosed onychomycosis, total (000s)
  • Prevalence of clinically diagnosed onychomycosis, males (000s)
  • Prevalence of clinically diagnosed onychomycosis, females (000s)
  • Clinically diagnosed onychomycosis by type at presentation, total (000s)
  • Clinically diagnosed onychomycosis by site of infection, total (000s)
  • Clinically diagnosed onychomycosis by main type of fungal pathogen, total (000s)
  • Clinically diagnosed onychomycosis by average duration of disease, total (000s)
  • Clinically diagnosed onychomycosis patients with diabetes, total (000s)
  • Clinically diagnosed onychomycosis patients with tinea pedis, total (000s)
  • Clinically diagnosed onychomycosis patients with hyperkeratosis, total (000s)
  • Clinically diagnosed onychomycosis patients with onycholysis, total (000s)
  • Clinically diagnosed onychomycosis patients with paronychia, total (000s)
  • USA Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • USA Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • France Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • France Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Germany Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Italy Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Spain Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Poland Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Poland Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • Japan Prevalence of onychomycosis by 5-yr age cohort, females (000s)
  • India Prevalence of onychomycosis by 5-yr age cohort, males (000s)
  • India Prevalence of onychomycosis by 5-yr age cohort, females (000s)
Back to Top